VolitionRx Limited has fully prepaid the $7.5 million senior secured convertible promissory note issued to Lind Global Asset Management more than eight months ahead of schedule. This early repayment eliminates further dilution risk to shareholders associated with the note. The company still has an outstanding $2.04 million note with Lind and continues to focus on improving its financial position by reducing debt and expenses to maximize shareholder value. VolitionRx specializes in developing blood tests for early disease detection and monitoring, aiming to improve patient outcomes.
Douglas Thompson, Chief Operating Officer of CAVA, purchased 6,500 shares of the company valued at $432,000. This insider buying could signal confidence in CAVA's future prospects. Investors often view such purchases as a positive sign, potentially i...
CBL & Associates Properties is rated as a Buy with a price target of $72 per share, indicating a 31.5% potential upside from current levels. The company trades at a forward price to adjusted funds from operations (P/AFFO) of 7.6x, which is a signific...
Bitcoin climbed above $77,800 and Ether increased about 2%, outperforming technology stocks. This rise in crypto prices comes amid growing optimism around the Clarity Act, which is set for a Senate vote on Tuesday. The positive sentiment in the crypt...
Ethereum's available supply on crypto exchanges has dropped to about 14.88 million ETH, a multi-year low, as around 6.4 million ETH left exchanges since July 2025 and staking absorbs a large share of circulating supply. Concurrently, U.S. Ethereum ET...
Satsuma Technology PLC has sold its entire Bitcoin treasury, disposing of 669.4867 Bitcoin in July and generating about £31.9 million. Following shareholder approval and a High Court order, the company will return roughly £30.7 million to investors b...
